Privia Health Group, Inc. (NASDAQ:PRVA) Receives $24.73 Average Price Target from Analysts

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have been given an average rating of “Buy” by the sixteen research firms that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation, twelve have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $24.73.

Several equities research analysts recently commented on the stock. Royal Bank of Canada reiterated an “outperform” rating and issued a $28.00 price objective on shares of Privia Health Group in a research report on Wednesday, August 14th. Robert W. Baird upped their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 26th. KeyCorp started coverage on shares of Privia Health Group in a research note on Friday, October 11th. They set an “overweight” rating and a $23.00 price objective for the company. Finally, Evercore ISI reduced their target price on Privia Health Group from $23.00 to $20.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 9th.

Privia Health Group Stock Up 1.4 %

NASDAQ:PRVA opened at $17.97 on Friday. The firm’s fifty day simple moving average is $18.50 and its 200-day simple moving average is $18.25. The stock has a market cap of $2.15 billion, a PE ratio of 149.76, a price-to-earnings-growth ratio of 4.01 and a beta of 0.76. Privia Health Group has a fifty-two week low of $15.92 and a fifty-two week high of $24.35.

Privia Health Group (NASDAQ:PRVA) last issued its earnings results on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). The company had revenue of $422.30 million during the quarter, compared to analysts’ expectations of $411.50 million. Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. The company’s quarterly revenue was up 2.2% on a year-over-year basis. During the same period last year, the business posted $0.06 earnings per share. Equities analysts anticipate that Privia Health Group will post 0.17 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Parth Mehrotra sold 135,142 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the transaction, the chief executive officer now directly owns 247,771 shares in the company, valued at $4,583,763.50. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 14.20% of the stock is owned by corporate insiders.

Institutional Trading of Privia Health Group

Institutional investors and hedge funds have recently made changes to their positions in the company. Canada Pension Plan Investment Board purchased a new stake in Privia Health Group during the second quarter valued at about $26,000. Nisa Investment Advisors LLC lifted its stake in shares of Privia Health Group by 107.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after purchasing an additional 930 shares in the last quarter. GAMMA Investing LLC increased its position in Privia Health Group by 98.7% during the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after purchasing an additional 845 shares in the last quarter. Signaturefd LLC raised its holdings in Privia Health Group by 46.3% in the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after buying an additional 626 shares during the period. Finally, Park Place Capital Corp raised its holdings in Privia Health Group by 115.4% in the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock valued at $49,000 after buying an additional 1,335 shares during the period. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.